"Women's Radio Network Open Forum" To Feature AxoGen, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
"Women's Radio Network Open Forum" To Feature AxoGen, Inc. CMO Jill Schiaparelli Discussing Women Suffering from Nerve Injuries and Options for Repair

ALACHUA, Fla., April 23, 2015 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN) , a leading medical technology company dedicated to peripheral nerve repair, announced today that Chief Marketing Officer Jill Schiaparelli will be interviewed live on a special afternoon segment of Women's Radio Network Open Forum, hosted by Lisa Singer. In this exclusive interview, Ms. Schiaparelli will discuss AxoGen's focus on helping people living with nerve damage, methods of diagnosis and new options for repair. Joining Jill will be special guest and patient Shirley Pincus, one of thousands of women who suffered from debilitating pain as a result of an undiagnosed nerve injury.

After more than 5 years of living day to day with pain, Shirley found a doctor who was able to identify that her pain was being caused by a nerve injury from decades earlier. Shortly after, her doctor performed a surgical procedure to remove the damaged nerve tissue from three places in Shirley's leg and repair it with AxoGen's Avance® Nerve Graft, processed donated human nerve tissue. Thanks to her perseverance, a proper diagnosis, expert surgeons, physical therapy and the generous donation of nerve tissue, Shirley is returning to everyday activity and is regaining her quality of life.

All shareholders, analysts, industry professionals are encouraged to listen to the live broadcast to hear more about Shirley's story and new options for repairing damaged nerves. See details below.

Date: Thursday, April 23, 2015 Start Time: 2:00pm ET| 1:00pm CT | 11:00am PT Network: Women's Radio Network – iHeart Radio Station: WRNW1 1100 AM Show: Women's Radio Network Open Forum - Special Afternoon Edition Host: Lisa Singer Live Stream: http://www.wrnw1.com/djs/lisa/

About "Women's Radio Network"

Women's Radio Network, "WRN", is a global, networking community for women professionals and entrepreneurs. Women's Radio Network offers interviews with the innovative, creative and successful women. Our interviewees tell their personal stories, share ideas and provide mentoring to fellow WRNW1 listeners regarding tenacity, leadership, motivation, ingenuity and overcoming obstacles. Join us while we celebrate you, and women like you as we broadcast their stories on Women's Radio Network, WRNW1.COM.

About Women's Radio Network Open Forum with Lisa Springer

Open Forum with Lisa Singer broadcasts normally broadcasts Monday through Friday, 9AM-12PM EST. Live interviews with executive and professional women across the globe.

About Lisa Singer

Award winning journalist Lisa Singer is a proven talent as a host, reporter, producer and writer for a multitude of media outlets that include WireImage Video, IntheKnowGuide, HSN, E! Entertainment Television, TNT and Court TV's "Hollywood Heat." She's been at the center of all things entertainment; reporting breaking news, interviewing Hollywood's biggest stars and covering the industry's most glamorous, red carpet events…including the Academy Awards, Emmys, blockbuster movie premieres and the prestigious Director's Guild Awards, among others. Lisa is also a contributing writer for Global Animal where she writes a lifestyle blog sharing tips and recipes for healthier and more compassionate eating.

Lisa and her dog Monty are a certified therapy team, volunteering at hospitals, senior centers and libraries where they help children read. A native of Massachusetts, she graduated from Boston University with a Bachelor of Arts degree in Broadcast Journalism.

About AxoGen, Inc.

AxoGen (NASDAQ: AXGN) is a leading medical technology company dedicated to peripheral nerve repair. AxoGen's portfolio of regenerative medicine products is available in the United States, Canada and several other countries and includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments.

To learn more about AxoGen and to sign up for news alerts, visit http://www.AxoGenInc.com .

Cautionary Statement Concerning Forward-Looking Statements

This Press Release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", "projects", "forecasts", "continue", "may", "should", "will" variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding our growth, our product development and product potential. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen's business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen's filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected. The forward-looking statements are representative only as of the date they are made, and, except as required by law, AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/04/prweb12666414.htm

AxoGen, Inc. Lee Robert "Bob" Johnston Jr, CFO +1 386.462.6856

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Securitize's Bold Move: Venturing into Asset-backed Lending

Updated Category News Views 48

Jumping into the Big League Securitize Corp. is shaking things up with its latest strategic move to acquire River One, an asset-backed financing firm. Now, this ain't just another run-of-the-mill acquisition to throw in the pile—it positions Securitize to plunge into the massive $6 trillion private asset-backed finance market. That's the kind of hefty expansion that...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
Ex-Special Ops Leader Fenton Joins SAGINT's Advisory Board

Updated Category News Views 22

If you’ve been around long enough, you know that in defense, the game’s all about who you know and how you move. And in this arena, General Bryan P. Fenton doesn’t just walk in—he bursts through the darn doors with gravitas honed by years commanding folks who live by grit and sinew. His latest move? Clambering aboard the SAGINT® Board of Advisors, ready to tackle...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 279

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 75

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Illinois Ban Risks Boosting Illicit THC Drink Sales

Updated Category News Views 61

Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...

Continue Reading
Celebrating Science with Southeastern Tile's Sponsorship

Updated Category News Views 65

Crafting Pathways and Fostering Curiosity In this world of rapid change and relentless innovation, supporting education—especially in science and technology—is like buying a piece of the future. And, boy, is Southeastern Tile Connection onto something with that. They've stepped up as an Exploration Sponsor for the Asheville Museum of Science's (AMOS) annual gala,...

Continue Reading
Ionis Faces Legal Scrutiny Amid Slashed Sales Forecast

Updated Category News Views 57

Ionis Pharmaceuticals Takes a Hit: What's Happening? November 9, 2026, wasn't just another dreary market day—especially if you've got a stake in Ionis Pharmaceuticals. Today, they whittled down their full-year sales forecast for TRYNGOLZA from a cozy $100 million to $110 million range to a startling $50 million. NASDAQ: IONS shares naturally took a nosedive, and as...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 69

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Euroseas Ltd. Gains Momentum with New Charter for M/V Jonathan P

Updated Category News Views 35

New Charter Contract for M/V Jonathan P Euroseas Ltd. (NASDAQ: ESEA), an esteemed player in the container shipping industry, proudly announces the establishment of a time charter contract for its 1,732 TEU feeder containership, M/V Jonathan P. This contract spans a minimum of 11 months and may extend to a maximum of 13 months at a favorable gross daily rate of $20,000....

Continue Reading
An In-depth Comparison of Micron Technology in the Chip Sector

Updated Category News Views 568

Understanding Micron Technology's Position in the Semiconductor Industry In the dynamic world of semiconductors, evaluating a company effectively is vital for investors looking to make educated decisions. This article provides a thorough comparison of Micron Technology (NASDAQ: MU) against its competitors, shedding light on essential financial metrics and growth...

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 70

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading
Marvell Technology Reports Impressive Q3 Earnings Growth

Updated Category News Views 269

Marvell Technology Posts Strong Q3 Earnings Marvell Technology Inc. (NASDAQ: MRVL) delivered an impressive financial performance for the third quarter, significantly surpassing market expectations. The company reported quarterly adjusted earnings of 76 cents per share, outperforming the analyst estimate of 73 cents, according to recent analytical reports. With quarterly...

Continue Reading
OkayCoin Launches Free Trial Staking for New Crypto Investors

Updated Category News Views 54

Introducing OkayCoin's Revolutionary Free Trial Liquid Staking OkayCoin has made an exciting move in the cryptocurrency sector by introducing a new Free Trial Liquid Staking program aimed at welcoming new investors. This innovative solution allows newcomers to experience the world of crypto staking with a minimal investment of just $100, providing an accessible entry...

Continue Reading